🇺🇸 FDA
Patent

US 11155599

Adenoviruses expressing heterologous tumor-associated antigens

granted A61KA61K2039/5256A61K39/0011

Quick answer

US patent 11155599 (Adenoviruses expressing heterologous tumor-associated antigens) held by The Board of Regents of the University of Texas System expires Mon Oct 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Oct 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K2039/5256, A61K39/0011, A61K39/001104, A61K39/001106